Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1427, 2004-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to PEP for HIV infections in Canada a problem
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 520, 2007-01 ,pp. :
Access to resources
Recommend
HIV-1 contacting and testing policy cuts PEP prescribing, costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 366, 2002-01 ,pp. :
Respiratory infections in patients with HIV
By Breen Ronan Johnson Margaret
Clinical Medicine, Vol. 33, Iss. 5, 1999-09 ,pp. :
Syphilis screen-and-treat programme good value for money
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 289, 2000-01 ,pp. :
Darunavir a powerful contender in HIV infections
Inpharma, Vol. 1, Iss. 1504, 2005-01 ,pp. :